COMPOUND PROFILE / PEPTIDES & ANALOGUES
Colivelin.
Research draftColivelin is an experimental Humanin-related hybrid peptide.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Colivelin is an experimental Humanin-related hybrid peptide.
Mechanism
Cell studies investigate neuroprotective signalling, including JAK/STAT pathways.
Human research
A therapeutic human evidence base was not established.
Preclinical & other research
Neuron and animal-injury models examined survival and axonal responses.
Safety & unknowns
Human exposure, immunogenicity and long-term safety are not established.
Regulatory status
Preclinical research candidate; component similarity does not validate Humanin-equivalent effects.
Reported use & evidence
The supplied Colivelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.